A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group trial
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 45 (3) , 303-306
- https://doi.org/10.1016/0090-8258(92)90309-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase I studies of trimetrexate using single and weekly dose schedulesInvestigational New Drugs, 1991
- A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-infection scheduleInvestigational New Drugs, 1990
- Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptideEuropean Journal of Cancer and Clinical Oncology, 1988
- Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.Journal of Clinical Oncology, 1987
- Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injectionsCancer Chemotherapy and Pharmacology, 1987
- Didemnin BInvestigational New Drugs, 1986
- Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitroBiochemical Pharmacology, 1984